Home/Vybion/Lee Henderson, PhD

LH

Lee Henderson, PhD

CEO

Therapeutic Areas

Neurodegenerative Diseases

Vybion Pipeline

Drug	Indication	Phase
INT41	Huntington's Disease	Pre-clinical

Leadership Team at Vybion

Martin Eglitis, PhD

Business Development

Marla Piercy, MS

Regulatory Affairs

View full Vybion profile